Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis

被引：12
|
作者：
Molica, Stefano [1 ]
Giannarelli, Diana [2 ]
Mirabelli, Rosanna [1 ]
Levato, Luciano [1 ]
Kay, Neil E. [3 ]
Shanafelt, Tait D. [4 ]
机构：
[1] Azienda Osped Pugliese Ciaccio, Dept Hematol Oncol, Viale Pio 10, I-88100 Catanzaro, Italy
[2] Regina Elena Natl Inst Canc Treatment & Res, Biostat Unit, Rome, Italy
[3] Mayo Clin, Div Hematol, Rochester, MN USA
[4] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA
来源：
BLOOD | 2018年 / 131卷 / 03期
关键词：
CLL-IPI; VALIDATION;
D O I：
10.1182/blood-2017-09-806034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：365 / 368
页数：4
相关论文
共 50 条
  • [1] Chronic Lymphocytic Leukemia International Prognostic INDEX (CLL-IPI) Predicts Prognosis of CLL: A Systematic Review and Meta-Analysis
    Molica, Stefano
    Giannarelli, Diana
    Levato, Luciano
    Mirabelli, Rosana
    Shanafelt, Tait D.
    [J]. BLOOD, 2017, 130
  • [2] THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI)-AN INTERNATIONAL META-ANALYSIS
    Bahlo, J.
    Kutsch, N.
    Bergmann, M.
    Byrd, J.
    Doehner, H.
    Eichhorst, B.
    Else, M.
    Geisler, C.
    Grever, M.
    Lepretre, S.
    Neuberg, D.
    Oscier, D.
    Robak, T.
    Rosenquist, R.
    Shanafelt, T.
    Stilgenbauer, S.
    Hallek, M.
    [J]. HAEMATOLOGICA, 2015, 100 : 313 - 314
  • [3] Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis
    Molica, Stefano
    Giannarelli, Diana
    Mirabelli, Rosanna
    Levato, Luciano
    Shanafelt, Tait D.
    [J]. ANNALS OF HEMATOLOGY, 2018, 97 (10) : 2005 - 2008
  • [4] Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis
    Stefano Molica
    Diana Giannarelli
    Rosanna Mirabelli
    Luciano Levato
    Tait D. Shanafelt
    [J]. Annals of Hematology, 2018, 97 : 2005 - 2008
  • [5] RITUXIMAB FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A SYSTEMATIC REVIEW WITH META-ANALYSIS
    Bauer, K.
    Rancea, M.
    Elter, T.
    Roloff, V.
    Hallek, M.
    Engert, A.
    Skoetz, N.
    [J]. HAEMATOLOGICA, 2012, 97 : 305 - 305
  • [6] RETRACTED ARTICLE: Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis
    Stefano Molica
    Diana Giannarelli
    [J]. Leukemia, 2021, 35 : 615 - 618
  • [7] Retraction Note: Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis
    Stefano Molica
    Diana Giannarelli
    [J]. Leukemia, 2023, 37 : 254 - 254
  • [8] RETRACTED: Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis (Retracted Article)
    Molica, Stefano
    Giannarelli, Diana
    [J]. LEUKEMIA, 2021, 35 (02) : 615 - 618
  • [9] Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis
    Wu, Yougen
    Wang, Yang
    Gu, Yuting
    Xia, Ju
    Kong, Xiaoyang
    Qian, Qingqing
    Hong, Yang
    [J]. HEMATOLOGY, 2017, 22 (10) : 578 - 584
  • [10] Ibrutinib as initial therapy in chronic lymphocytic leukemia: A systematic review and meta-analysis
    Molica, Stefano
    Giannarelli, Diana
    Baumann, Tycho
    Montserrat, Emili
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (05) : 512 - 515
12345